BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4555783)

  • 1. Acute and steady-state insulin responses to glucose in nonobese diabetic subjects.
    Lerner RL; Porte D
    J Clin Invest; 1972 Jul; 51(7):1624-31. PubMed ID: 4555783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epinephrine: selective inhibition of the acute insulin response to glucose.
    Lerner RL; Porte D
    J Clin Invest; 1971 Nov; 50(11):2453-7. PubMed ID: 4938132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of secretin-stimulated insulin responses in man.
    Lerner RL; Porte D
    J Clin Invest; 1972 Aug; 51(8):2205-10. PubMed ID: 4559947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose.
    Goodner CJ; Conway MJ; Werbach JH
    J Clin Invest; 1969 Oct; 48(10):1878-87. PubMed ID: 5822593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus.
    Robertson RP; Chen M
    J Clin Invest; 1977 Sep; 60(3):747-53. PubMed ID: 330566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
    DeFronzo R; Deibert D; Hendler R; Felig P; Soman V
    J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for endogenous prostaglandins in defective glucose potentiation of nonglucose insulin secretagogues in diabetics.
    McRae JR; Metz SA; Robertson RP
    Metabolism; 1981 Nov; 30(11):1065-75. PubMed ID: 7026970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin.
    Navalesi R; Pilo A; Ferrannini E
    J Clin Invest; 1978 Jan; 61(1):197-208. PubMed ID: 338630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.
    Palmer JP; Benson JW; Walter RM; Ensinck JW
    J Clin Invest; 1976 Sep; 58(3):565-70. PubMed ID: 783201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired insulin secretion in human diabetes mellitus. Interactions between naloxone, phentolamine and lysine acetylsalicylate upon glucose induced insulin release.
    Giugliano D; Di Pinto P; Ceriello A; Saccomanno F; Passariello N; D'Onofrio F
    Diabete Metab; 1985 Dec; 11(6):350-8. PubMed ID: 3936737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic responses to monocomponent human insulin infusions in normal subjects and patients with liver and endocrine disease.
    West TE; Owens D; Sönksen PH; Srivastava MC; Tompkins CV; Nabarro JD
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):573-84. PubMed ID: 1104216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoproterenol-stimulated C-peptide and insulin secretion in diabetic and nonobese normal subjects: decreased hepatic extraction of endogenous insulin in diabetes.
    Sando H; Lee YS; Iwamoto Y; Ikeuchi M; Kosaka K
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1143-9. PubMed ID: 6999008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of diabetes mellitus and insulin on the turnover and metabolic response to ketones in man.
    Sherwin RS; Hendler RG; Felig P
    Diabetes; 1976 Sep; 25(9):776-84. PubMed ID: 955305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood ketone body disappearance rate in diabetics and normals after rapid infusion of dl-3-hydroxybutyrate. Studies before and after diabetic treatment.
    Wildenhoff KE
    Acta Med Scand; 1976; 200(1-2):79-86. PubMed ID: 822695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma insulin response to glucose infusion in obese non-diabetic and diabetic subjects.
    Velemínský J
    Horm Metab Res; 1980 Dec; 12(12):651-5. PubMed ID: 7009366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal secretion of insulin and glucagon by the in vitro perfused pancreas of the genetically diabetic Chinese hamster.
    Frankel BJ; Gerich JE; Hagura R; Fanska RE; Gerritsen GC; Grodsky GM
    J Clin Invest; 1974 Jun; 53(6):1637-46. PubMed ID: 4830228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.
    Seltzer HS; Allen EW; Herron AL; Brennan MT
    J Clin Invest; 1967 Mar; 46(3):323-35. PubMed ID: 6023769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.